Eli Lilly (LLY) Faces a Slide in Market Value
The stock of Eli Lilly & Co. (ticker LLY) closed 2.54 % lower during the 24‑hour window that ended at 06:39 AM Central European Time on Monday, 26 November 2026. At the close, the share price stood at USD 1,273.46. The company’s shares are presently circulating in a volume of 895.2 million outstanding, which translates to a market capitalisation of approximately USD 1.1 trillion.
During the most recent 24‑hour period, the firm traded USD 2.9 billion in shares. This follows a 7.75 % rally since the end of the preceding month, indicating that investors had been optimistic before the recent dip. The 200‑day simple moving average sits at USD 1,084.94, placing the current price well above that historical mean. Over the last 52 weeks, LLY’s highest recorded price was USD 1,321.21 on 22 October 2026, while its lowest stood at USD 809.63 on 29 October 2025.
Performance Context within the Market
In the same 24‑hour window, several other prominent stocks moved in varying directions:
| Stock | Ticker | 24‑h change | Current price | Market cap | P/E ratio |
|---|---|---|---|---|---|
| Mastercard | MA | –1.52 % | USD 623.60 | USD 546.3 bn | 34.21 |
| Berkshire Hathaway | BKHT | 0 % | USD 813,595 | USD 1.2 trillion | 13.61 |
| Johnson & Johnson | JNJ | –1.42 % | USD 263.81 | USD 635.1 bn | 29.18 |
| Micron | MU | +2.46 % | USD 877.55 | USD 992.9 bn | 11.82 |
| AbbVie | ABBV | +0.16 % | USD 285.64 | USD 504.8 bn | 80.68 |
These data points illustrate that LLY’s decline was not mirrored across the board; while some peers gained, others lagged or remained flat.
Company Profile
Eli Lilly & Co. is headquartered in Indianapolis, United States, and operates as a global healthcare enterprise. The firm’s core activities encompass the discovery, development, manufacturing, and sale of pharmaceutical products for both human and veterinary use. Its portfolio spans several therapeutic areas, including neuroscience, endocrinology, anti‑infectives, cardiovascular agents, oncology, and animal health. The company’s products reach markets worldwide, and its shares are listed on the New York Stock Exchange. For more detailed information on the company’s offerings, one may visit its official website at www.lilly.com .
This article provides a snapshot of Eli Lilly’s recent market performance and contextualizes it within broader sector movements, offering investors a concise yet comprehensive view of the company’s standing.
